HEADER PLASMA PROTEIN 29-AUG-00 1E7E TITLE HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID TITLE 2 (CAPRIC ACID) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELLULAR_LOCATION: SERUM; SOURCE 6 GENE: ALB; SOURCE 7 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 4932 KEYWDS PLASMA PROTEIN, METAL-BINDING, LIPID-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR A.A.BHATTACHARYA,T.GRUENE,S.CURRY REVDAT 2 24-FEB-09 1E7E 1 VERSN REVDAT 1 06-NOV-00 1E7E 0 JRNL AUTH A.A.BHATTACHARYA,T.GRUNE,S.CURRY JRNL TITL CRYSTALLOGRAPHIC ANALYSIS REVEALS COMMON MODES OF JRNL TITL 2 BINDING OF MEDIUM AND LONG-CHAIN FATTY ACIDS TO JRNL TITL 3 HUMAN SERUM ALBUMIN JRNL REF J.MOL.BIOL. V. 303 721 2000 JRNL REFN ISSN 0022-2836 JRNL PMID 11061971 JRNL DOI 10.1006/JMBI.2000.4158 REMARK 2 REMARK 2 RESOLUTION. 2.5 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000000.00 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.001000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 22984 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.7 REMARK 3 FREE R VALUE TEST SET COUNT : 1090 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.4 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2758 REMARK 3 BIN R VALUE (WORKING SET) : 0.357 REMARK 3 BIN FREE R VALUE : 0.364 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.3 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 154 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.029 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4455 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.0 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00 REMARK 3 B22 (A**2) : 0.00 REMARK 3 B33 (A**2) : 0.00 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.47 REMARK 3 LOW RESOLUTION CUTOFF (A) : 40.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.2 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.0 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.60 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.69 ; 1.50 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.90 ; 2.00 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.60 ; 2.00 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.31 ; 2.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DEC.PAR REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : TOPH19.SOL REMARK 3 TOPOLOGY FILE 3 : DEC.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED RESIDUES ASP REMARK 3 1, ALA 2 AND LEU 585 ARE DISORDERED AND HAVE NOT BEEN INCLUDED REMARK 3 IN THE MODEL. REMARK 4 REMARK 4 1E7E COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 29-AUG-00. REMARK 100 THE PDBE ID CODE IS EBI-5325. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-99 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX9.6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22984 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 37.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : 0.07000 REMARK 200 FOR THE DATA SET : 9.4400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.27300 REMARK 200 R SYM FOR SHELL (I) : 0.27300 REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: 1BJ5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 93.39000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 19.59500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 93.39000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 19.59500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 HOH 2030 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 SERUM ALBUMIN, REGULATES THE COLLOIDAL OSMOTIC PRESSURE OF BLOOD REMARK 400 IT BINDS TO WATER, CA++, NA+, K+, FATTY ACIDS, HORMONES, REMARK 400 BILIRUBIN AND DRUGS REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 LEU A 585 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 4 CE NZ REMARK 470 LYS A 41 CE NZ REMARK 470 LYS A 73 CG CD CE NZ REMARK 470 GLN A 94 CG CD OE1 NE2 REMARK 470 ASP A 108 CG OD1 OD2 REMARK 470 ASN A 109 CG OD1 ND2 REMARK 470 GLU A 119 CD OE1 OE2 REMARK 470 GLN A 170 CG CD OE1 NE2 REMARK 470 LYS A 181 NZ REMARK 470 ARG A 186 CZ NH1 NH2 REMARK 470 LYS A 195 CD CE NZ REMARK 470 ARG A 197 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 204 CG CD OE1 NE2 REMARK 470 LYS A 276 CG CD CE NZ REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 GLU A 294 CG CD OE1 OE2 REMARK 470 ASP A 301 CG OD1 OD2 REMARK 470 LYS A 313 CG CD CE NZ REMARK 470 LYS A 351 CG CD CE NZ REMARK 470 HIS A 367 ND1 CD2 CE1 NE2 REMARK 470 LYS A 372 CG CD CE NZ REMARK 470 LYS A 389 CD CE NZ REMARK 470 GLN A 390 CD OE1 NE2 REMARK 470 LYS A 439 CG CD CE NZ REMARK 470 LYS A 475 CG CD CE NZ REMARK 470 GLU A 492 CG CD OE1 OE2 REMARK 470 LYS A 500 CG CD CE NZ REMARK 470 GLU A 501 CG CD OE1 OE2 REMARK 470 GLU A 505 CG CD OE1 OE2 REMARK 470 PHE A 509 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 518 CG CD OE1 OE2 REMARK 470 LYS A 519 CG CD CE NZ REMARK 470 GLU A 520 CG CD OE1 OE2 REMARK 470 ARG A 521 CZ NH1 NH2 REMARK 470 LYS A 524 CE NZ REMARK 470 LYS A 536 CG CD CE NZ REMARK 470 LYS A 538 CD CE NZ REMARK 470 LYS A 541 CG CD CE NZ REMARK 470 ASP A 549 CG OD1 OD2 REMARK 470 GLU A 556 CG CD OE1 OE2 REMARK 470 LYS A 557 CD CE NZ REMARK 470 ASP A 562 CG OD1 OD2 REMARK 470 LYS A 564 CG CD CE NZ REMARK 470 THR A 566 OG1 CG2 REMARK 470 PHE A 568 CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 570 CG CD OE1 OE2 REMARK 470 LYS A 573 CD CE NZ REMARK 470 GLN A 580 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 61 -19.61 65.23 REMARK 500 LEU A 80 -47.87 -29.48 REMARK 500 CYS A 91 0.01 -63.23 REMARK 500 HIS A 105 23.32 -79.09 REMARK 500 ASN A 111 79.12 -119.48 REMARK 500 PRO A 118 -176.75 -63.58 REMARK 500 TYR A 150 108.46 -52.54 REMARK 500 PHE A 223 70.56 -114.22 REMARK 500 ILE A 271 -65.24 -105.11 REMARK 500 VAL A 293 153.74 -35.23 REMARK 500 PRO A 299 137.32 -37.55 REMARK 500 PRO A 303 -165.94 -45.25 REMARK 500 SER A 312 132.18 -25.06 REMARK 500 LYS A 313 66.03 -108.03 REMARK 500 ASP A 314 -11.17 -165.65 REMARK 500 ALA A 322 89.06 -171.68 REMARK 500 CYS A 361 4.03 -68.21 REMARK 500 ALA A 364 -92.99 -20.30 REMARK 500 HIS A 367 3.44 -55.01 REMARK 500 LYS A 372 43.44 -89.49 REMARK 500 VAL A 469 -30.71 -143.05 REMARK 500 GLU A 479 -170.86 -66.57 REMARK 500 TYR A 497 130.67 -24.01 REMARK 500 PRO A 499 151.59 -36.10 REMARK 500 ALA A 511 9.59 -51.67 REMARK 500 THR A 515 47.72 -109.05 REMARK 500 LYS A 564 -88.53 -94.81 REMARK 500 GLU A 565 -4.35 -50.97 REMARK 500 GLN A 580 -35.85 -39.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 GLU A 95 24.8 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 DKA A 1004 REMARK 610 DKA A 1001 REMARK 610 DKA A 1002 REMARK 610 DKA A 1005 REMARK 610 DKA A 1006 REMARK 610 DKA A 1007 REMARK 610 DKA A 1010 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1007 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1008 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DKA A1009 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1BJ5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1BKE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND REMARK 900 TRI-IODOBENZOIC ACID REMARK 900 RELATED ID: 1BM0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E7A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH REMARK 900 THE GENERAL ANESTHETIC PROPOFOL REMARK 900 RELATED ID: 1E7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH REMARK 900 HALOTHANE REMARK 900 RELATED ID: 1E7C RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE REMARK 900 GENERAL ANESTHETIC HALOTHANE REMARK 900 RELATED ID: 1E7F RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID REMARK 900 RELATED ID: 1E7G RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1E7H RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID REMARK 900 RELATED ID: 1E7I RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID REMARK 900 RELATED ID: 1UOR RELATED DB: PDB REMARK 900 X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES REMARK 900 DETERMINED BY MOLECULAR REPLACEMENT METHOD, USING LOW REMARK 900 RESOLUTION STRUCTURE MODEL OF TETRAGONAL FORM OF HUMAN REMARK 900 SERUM ALBUMIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 1BJ5 SWS P02768 1 - 26 NOT IN ATOMS LIST REMARK 999 1BJ5 SWS P02768 609 - 609 NOT IN ATOMS LIST DBREF 1E7E A 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET DKA A1001 11 HET DKA A1002 10 HET DKA A1003 9 HET DKA A1004 12 HET DKA A1005 11 HET DKA A1006 11 HET DKA A1007 10 HET DKA A1008 12 HET DKA A1009 12 HET DKA A1010 8 HETNAM DKA DECANOIC ACID FORMUL 2 DKA 10(C10 H20 O2) FORMUL 12 HOH *30(H2 O1) HELIX 1 1 SER A 5 GLY A 15 1 11 HELIX 2 2 GLY A 15 LEU A 31 1 17 HELIX 3 3 PRO A 35 ASP A 56 1 22 HELIX 4 4 SER A 65 CYS A 75 1 11 HELIX 5 5 THR A 76 VAL A 77 5 2 HELIX 6 7 THR A 79 TYR A 84 1 6 HELIX 7 8 GLY A 85 LYS A 93 5 9 HELIX 8 9 GLN A 94 HIS A 105 1 12 HELIX 9 10 GLU A 119 ASN A 130 1 12 HELIX 10 11 ASN A 130 HIS A 146 1 17 HELIX 11 12 TYR A 150 CYS A 169 1 20 HELIX 12 13 ASP A 173 PHE A 206 1 34 HELIX 13 14 GLY A 207 PHE A 223 1 17 HELIX 14 15 GLU A 227 GLY A 248 1 22 HELIX 15 16 ASP A 249 ASN A 267 1 19 HELIX 16 17 ASN A 267 SER A 272 1 6 HELIX 17 18 PRO A 282 VAL A 293 1 12 HELIX 18 19 SER A 304 VAL A 310 1 7 HELIX 19 20 ASP A 314 ALA A 322 1 9 HELIX 20 21 ALA A 322 ARG A 337 1 16 HELIX 21 22 SER A 342 CYS A 361 1 20 HELIX 22 23 ASP A 365 CYS A 369 5 5 HELIX 23 24 TYR A 370 ASP A 375 5 6 HELIX 24 25 GLU A 376 GLU A 396 1 21 HELIX 25 26 GLY A 399 VAL A 415 1 17 HELIX 26 27 SER A 419 CYS A 438 1 20 HELIX 27 28 LYS A 444 THR A 467 1 24 HELIX 28 29 SER A 470 GLU A 479 1 10 HELIX 29 30 ASN A 483 LEU A 491 1 9 HELIX 30 31 ASN A 503 THR A 508 5 6 HELIX 31 32 HIS A 510 LEU A 516 5 7 HELIX 32 33 SER A 517 LYS A 536 1 20 HELIX 33 34 THR A 540 CYS A 559 1 20 HELIX 34 35 THR A 566 LEU A 583 1 18 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.03 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.04 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.03 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.02 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.03 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.03 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.03 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.02 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.03 SSBOND 17 CYS A 558 CYS A 567 1555 1555 2.02 SITE 1 AC1 5 ARG A 117 LEU A 135 TYR A 138 TYR A 161 SITE 2 AC1 5 HOH A2015 SITE 1 AC2 6 TYR A 150 ALA A 254 ARG A 257 LEU A 283 SITE 2 AC2 6 LEU A 284 SER A 287 SITE 1 AC3 9 SER A 342 VAL A 344 ARG A 348 PRO A 384 SITE 2 AC3 9 LEU A 387 ILE A 388 ALA A 449 LEU A 453 SITE 3 AC3 9 ARG A 485 SITE 1 AC4 6 ARG A 410 TYR A 411 VAL A 415 LEU A 460 SITE 2 AC4 6 PHE A 488 SER A 489 SITE 1 AC5 4 TYR A 401 LYS A 525 LEU A 532 MET A 548 SITE 1 AC6 4 PHE A 206 ALA A 210 SER A 480 LEU A 481 SITE 1 AC7 4 LEU A 219 ARG A 222 LEU A 260 ALA A 291 SITE 1 AC8 5 ASP A 187 LYS A 190 ASN A 429 LYS A 436 SITE 2 AC8 5 GLN A 459 SITE 1 AC9 5 LYS A 195 LEU A 198 SER A 202 SER A 454 SITE 2 AC9 5 LEU A 481 CRYST1 186.780 39.190 95.340 90.00 105.15 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005354 0.000000 0.001450 0.00000 SCALE2 0.000000 0.025517 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010866 0.00000 MASTER 442 0 10 34 0 0 16 6 0 0 0 45 END